Breast cancer in young women: do BRCA1 or BRCA2 mutations matter?

Lancet Oncol. 2018 Feb;19(2):150-151. doi: 10.1016/S1470-2045(18)30008-1. Epub 2018 Jan 11.

Author

Peter A Fasching¹

Affiliation

¹ Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Bavaria, 91054, Germany. Electronic address: peter.fasching@uk-erlangen.de.

PMID: 29337093
DOI: 10.1016/S1470-2045(18)30008-1

No abstract available

Publication types

Comment

MeSH terms

BRCA1 Protein / genetics*
BRCA2 Protein / genetics
Breast Neoplasms*
Female
Humans
Mutation
Prospective Studies

Substances

BRCA1 Protein
BRCA2 Protein
BRCA2 protein, human